Clobazam Suspension
Product Images NDC 51672-4227

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Clobazam (NDC 51672-4227). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Taro Pharmaceuticals U.s.a., Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Clobazam 01)

FDA Label Image

Figure 1 (Clobazam 02)

FDA Label Image

Figure 2 (Clobazam 03)

Figure 2 (Clobazam 03)
The text appears to be a table showing the percentage of patients who received either a placebo or different doses of Clobazam and their corresponding reduction in the weekly drop seizure frequency from baseline. Therefore, this table is likely taken from a clinical trial or study evaluating the effectiveness of Clobazam in treating drop seizures.*
FDA Label Image

Figure A (Clobazam 04)

FDA Label Image

Figure B (Clobazam 05)

FDA Label Image

Figure C (Clobazam 06)

FDA Label Image

Figure D (Clobazam 07)

Figure D (Clobazam 07)
This appears to be a list of items related to medical or pharmaceutical equipment. It mentions "Dosage indicators" as an unidentified tool, a "Tip" and "Barrel" which could refer to syringe components, and a "Plunger" which is also found in syringes. It is possible that this text is part of a guide or manual detailing how to use or maintain these tools.*
FDA Label Image

Figure E (Clobazam 08)

FDA Label Image

Figure F (Clobazam 09)

FDA Label Image

Figure G (Clobazam 10)

FDA Label Image

Figure H (Clobazam 11)

FDA Label Image

Figure I (Clobazam 12)

Figure I (Clobazam 12)
This text is discussing two different things: SMS and a medication called Clobazam, specifically the brand name "Secnansio 7". No further context or information is available.*
FDA Label Image

Principal Display Panel (120 mL Bottle Carton)

Principal Display Panel (120 mL Bottle Carton)
This is a description of a medication named Clobazam available in 120mL Oral Suspension formulation for oral administration using a prescription. The package contains an enclosed medication instruction guide, and the medication should only be given to the person for whom it was prescribed. The text also provides product and company identification numbers.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.